Browsing Wolfson Institute of Preventive Medicine by Author "Robling, M"
Now showing items 1-5 of 5
-
Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK: a cross-sectional population survey
Quinn-Scoggins, HD; Cannings-John, R; Moriarty, Y; Whitelock, V; Whitaker, KL; Grozeva, D; Hughes, J; Townson, J; Osborne, K; Goddard, M (2021) -
Health behaviour change among UK adults during the pandemic: findings from the COVID-19 cancer attitudes and behaviours study
Anyanwu, P; Moriarty, Y; McCutchan, G; Grozeva, D; Goddard, M; Whitelock, V; Cannings-John, R; Quinn-Scoggins, H; Hughes, J; Gjini, A (2022) -
Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: A mixed-methods study
Wilson, R; Quinn-Scoggins, H; Moriarty, Y; Hughes, J; Goddard, M; Cannings-John, R; Whitelock, V; Whitaker, KL; Grozeva, D; Townson, J (2021) -
Satisfaction with remote consultations in primary care during COVID-19: a population survey of UK adults
Lifford, KJ; Grozeva, D; Cannings-John, R; Quinn-Scoggins, HD; Moriarty, Y; Gjini, A; Goddard, M; Hepburn, J; Hughes, J; Moore, G -
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage.
Toader, A-M; Campbell, MK; Quint, JK; Robling, M; Sydes, MR; Thorn, J; Wright-Hughes, A; Yu, L-M; Abbott, TEF; Bond, S (2024-01-29)BACKGROUND: Healthcare system data (HSD) are increasingly used in clinical trials, augmenting or replacing traditional methods of collecting outcome data. This study, PRIMORANT, set out to identify, in the UK context, ...